Richter Expects Esmya Sales To Drop 50% Following EU Restrictions Over Liver Concerns

 
• By Ian Schofield
  
The EU has imposed safety restrictions on Esmya that could cut its sales in half
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip